<?xml version="1.0" encoding="UTF-8"?><TED_EXPORT xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="http://publications.europa.eu/resource/schema/ted/R2.0.9/publication" xmlns:n2016="http://publications.europa.eu/resource/schema/ted/2016/nuts" xsi:schemaLocation="http://publications.europa.eu/resource/schema/ted/R2.0.9/publication TED_EXPORT.xsd" VERSION="R2.0.9.S03.E01" DOC_ID="370802-2020" EDITION="2020152"><TECHNICAL_SECTION><RECEPTION_ID>20-381730-001</RECEPTION_ID><DELETION_DATE>20201111</DELETION_DATE><FORM_LG_LIST>ES </FORM_LG_LIST><COMMENTS>From Convertor</COMMENTS></TECHNICAL_SECTION><LINKS_SECTION><XML_SCHEMA_DEFINITION_LINK xlink:type="simple" xlink:href="http://ted.europa.eu" xlink:title="TED WEBSITE"/><OFFICIAL_FORMS_LINK xlink:type="simple" xlink:href="http://ted.europa.eu"/><FORMS_LABELS_LINK xlink:type="simple" xlink:href="http://ted.europa.eu"/><ORIGINAL_CPV_LINK xlink:type="simple" xlink:href="http://ted.europa.eu"/><ORIGINAL_NUTS_LINK xlink:type="simple" xlink:href="http://ted.europa.eu"/></LINKS_SECTION><CODED_DATA_SECTION><REF_OJS><COLL_OJ>S</COLL_OJ><NO_OJ>152</NO_OJ><DATE_PUB>20200807</DATE_PUB></REF_OJS><NOTICE_DATA><NO_DOC_OJS>2020/S 152-370802</NO_DOC_OJS><URI_LIST><URI_DOC LG="ES">http://ted.europa.eu/udl?uri=TED:NOTICE:370802-2020:TEXT:ES:HTML</URI_DOC></URI_LIST><LG_ORIG>ES</LG_ORIG><ISO_COUNTRY VALUE="ES"/><IA_URL_GENERAL>http://www.fhalcorcon.es</IA_URL_GENERAL><ORIGINAL_CPV CODE="33652000">Antineoplastic and immunomodulating agents</ORIGINAL_CPV><ORIGINAL_CPV CODE="33620000">Medicinal products for the blood, blood-forming organs and the cardiovascular system</ORIGINAL_CPV><ORIGINAL_CPV CODE="33661000">Medicinal products for the nervous system</ORIGINAL_CPV><ORIGINAL_CPV CODE="33630000">Medicinal products for dermatology and the musculo-skeletal system</ORIGINAL_CPV><ORIGINAL_CPV CODE="33662100">Ophthalmologicals</ORIGINAL_CPV><ORIGINAL_CPV CODE="33652300">Immunosuppressive agents</ORIGINAL_CPV><ORIGINAL_CPV CODE="33670000">Medicinal products for the respiratory system</ORIGINAL_CPV><n2016:PERFORMANCE_NUTS CODE="ES300">Madrid</n2016:PERFORMANCE_NUTS><n2016:CA_CE_NUTS CODE="ES300">Madrid</n2016:CA_CE_NUTS><n2016:TENDERER_NUTS CODE="ES511">Barcelona</n2016:TENDERER_NUTS><VALUES><VALUE TYPE="PROCUREMENT_TOTAL" CURRENCY="EUR">2724077.68</VALUE></VALUES></NOTICE_DATA><CODIF_DATA><DS_DATE_DISPATCH>20200803</DS_DATE_DISPATCH><AA_AUTHORITY_TYPE CODE="8">Other</AA_AUTHORITY_TYPE><TD_DOCUMENT_TYPE CODE="7">Contract award notice</TD_DOCUMENT_TYPE><NC_CONTRACT_NATURE CODE="2">Supplies</NC_CONTRACT_NATURE><PR_PROC CODE="T">Negotiated without a prior call for competition</PR_PROC><RP_REGULATION CODE="4">European Union</RP_REGULATION><TY_TYPE_BID CODE="9">Not applicable</TY_TYPE_BID><AC_AWARD_CRIT CODE="1">Lowest price</AC_AWARD_CRIT><MA_MAIN_ACTIVITIES CODE="H">Health</MA_MAIN_ACTIVITIES><HEADING>01B03</HEADING><INITIATOR>01</INITIATOR></CODIF_DATA></CODED_DATA_SECTION><TRANSLATION_SECTION><ML_TITLES><ML_TI_DOC LG="BG"><TI_CY>Иcпaния</TI_CY><TI_TOWN>Alcorcón</TI_TOWN><TI_TEXT><P>Антинеопластични средства и имуномодулатори</P></TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="CS"><TI_CY>Španělsko</TI_CY><TI_TOWN>Alcorcón</TI_TOWN><TI_TEXT><P>Antineoplastika a imunomodulátory</P></TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="DA"><TI_CY>Spanien</TI_CY><TI_TOWN>Alcorcón</TI_TOWN><TI_TEXT><P>Antineoplastiske og immunmodulerende midler</P></TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="DE"><TI_CY>Spanien</TI_CY><TI_TOWN>Alcorcón</TI_TOWN><TI_TEXT><P>Antineoplastische und immunmodulierende Mittel</P></TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="EL"><TI_CY>Ισπανία</TI_CY><TI_TOWN>Alcorcón</TI_TOWN><TI_TEXT><P>Αντινεοπλασματικά και ανοσορρυθμιστικά φάρμακα</P></TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="EN"><TI_CY>Spain</TI_CY><TI_TOWN>Alcorcón</TI_TOWN><TI_TEXT><P>Antineoplastic and immunomodulating agents</P></TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="ES"><TI_CY>España</TI_CY><TI_TOWN>Alcorcón</TI_TOWN><TI_TEXT><P>Agentes antineoplásicos e inmunomoduladores</P></TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="ET"><TI_CY>Hispaania</TI_CY><TI_TOWN>Alcorcón</TI_TOWN><TI_TEXT><P>Antineoplastilised ja immuunmoduleerivad ained</P></TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="FI"><TI_CY>Espanja</TI_CY><TI_TOWN>Alcorcón</TI_TOWN><TI_TEXT><P>Solunsalpaajat ja sytostaatit sekä immunomodulantit</P></TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="FR"><TI_CY>Espagne</TI_CY><TI_TOWN>Alcorcón</TI_TOWN><TI_TEXT><P>Antinéoplasiques et immunomodulateurs</P></TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="GA"><TI_CY>Spáinn, an</TI_CY><TI_TOWN>Alcorcón</TI_TOWN><TI_TEXT><P>Antineoplastic and immunomodulating agents</P></TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="HR"><TI_CY>Španjolska</TI_CY><TI_TOWN>Alcorcón</TI_TOWN><TI_TEXT><P>Antineoplastični lijekovi i imunomodulatori</P></TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="HU"><TI_CY>Spanyolország</TI_CY><TI_TOWN>Alcorcón</TI_TOWN><TI_TEXT><P>Daganatellenes és immunmodulátor szerek</P></TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="IT"><TI_CY>Spagna</TI_CY><TI_TOWN>Alcorcón</TI_TOWN><TI_TEXT><P>Agenti antineoplastici e immunomodulatori</P></TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="LT"><TI_CY>Ispanija</TI_CY><TI_TOWN>Alcorcón</TI_TOWN><TI_TEXT><P>Antinavikiniai vaistai ir imunomoduliatoriai</P></TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="LV"><TI_CY>Spānija</TI_CY><TI_TOWN>Alcorcón</TI_TOWN><TI_TEXT><P>Antineoplastiskie līdzekļi un imūnmodulatori</P></TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="MT"><TI_CY>Spanja</TI_CY><TI_TOWN>Alcorcón</TI_TOWN><TI_TEXT><P>Aġenti ta' l-antineoplastika u ta' l-immunomodulaturi</P></TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="NL"><TI_CY>Spanje</TI_CY><TI_TOWN>Alcorcón</TI_TOWN><TI_TEXT><P>Antineoplastische en immunomodulerende middelen</P></TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="PL"><TI_CY>Hiszpania</TI_CY><TI_TOWN>Alcorcón</TI_TOWN><TI_TEXT><P>Środki przeciwnowotworowe i immunomodulacyjne</P></TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="PT"><TI_CY>Espanha</TI_CY><TI_TOWN>Alcorcón</TI_TOWN><TI_TEXT><P>Antineoplásicos e imunomoduladores</P></TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="RO"><TI_CY>Spania</TI_CY><TI_TOWN>Alcorcón</TI_TOWN><TI_TEXT><P>Antineoplazice şi imunomodulatoare</P></TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="SK"><TI_CY>Španielsko</TI_CY><TI_TOWN>Alcorcón</TI_TOWN><TI_TEXT><P>Antineoplastické a imunomodulačné činidlá</P></TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="SL"><TI_CY>Španija</TI_CY><TI_TOWN>Alcorcón</TI_TOWN><TI_TEXT><P>Zdravila z delovanjem na novotvorbe in imunomodulatorji</P></TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="SV"><TI_CY>Spanien</TI_CY><TI_TOWN>Alcorcón</TI_TOWN><TI_TEXT><P>Cytostatika/cytotoxiska medel och immunmodulerande medel</P></TI_TEXT></ML_TI_DOC></ML_TITLES><ML_AA_NAMES><AA_NAME LG="ES">Hospital Universitario Fundación Alcorcón</AA_NAME></ML_AA_NAMES></TRANSLATION_SECTION><FORM_SECTION><F03_2014 CATEGORY="ORIGINAL" FORM="F03" LG="ES"><LEGAL_BASIS VALUE="32014L0024"/><CONTRACTING_BODY><ADDRESS_CONTRACTING_BODY><OFFICIALNAME>Hospital Universitario Fundación Alcorcón</OFFICIALNAME><NATIONALID>G81602237</NATIONALID><ADDRESS>C/ Budapest, 1</ADDRESS><TOWN>Alcorcón</TOWN><POSTAL_CODE>28922</POSTAL_CODE><COUNTRY VALUE="ES"/><PHONE>+34 916219541 / 916219439 / 916219232</PHONE><E_MAIL>licitaciones@fhalcorcon.es</E_MAIL><FAX>+34 916219496</FAX><n2016:NUTS CODE="ES300"/><URL_GENERAL>http://www.fhalcorcon.es</URL_GENERAL><URL_BUYER>http://www.madrid.org/contratospublicos</URL_BUYER></ADDRESS_CONTRACTING_BODY><CA_TYPE_OTHER>Fundación</CA_TYPE_OTHER><CA_ACTIVITY VALUE="HEALTH"/></CONTRACTING_BODY><OBJECT_CONTRACT><TITLE><P>Suministro de medicamentos exclusivos de Novartis Farmacéutica, S. A., para el Hospital Universitario Fundación Alcorcón</P></TITLE><REFERENCE_NUMBER>PNSP-SUM 018/20</REFERENCE_NUMBER><CPV_MAIN><CPV_CODE CODE="33652000"/></CPV_MAIN><TYPE_CONTRACT CTYPE="SUPPLIES"/><SHORT_DESCR><P>Suministro de medicamentos exclusivos de Novartis Farmacéutica, S. A.</P></SHORT_DESCR><VAL_TOTAL CURRENCY="EUR">2724077.68</VAL_TOTAL><NO_LOT_DIVISION/><OBJECT_DESCR ITEM="1"><CPV_ADDITIONAL><CPV_CODE CODE="33620000"/></CPV_ADDITIONAL><CPV_ADDITIONAL><CPV_CODE CODE="33661000"/></CPV_ADDITIONAL><CPV_ADDITIONAL><CPV_CODE CODE="33630000"/></CPV_ADDITIONAL><CPV_ADDITIONAL><CPV_CODE CODE="33662100"/></CPV_ADDITIONAL><CPV_ADDITIONAL><CPV_CODE CODE="33652300"/></CPV_ADDITIONAL><CPV_ADDITIONAL><CPV_CODE CODE="33670000"/></CPV_ADDITIONAL><n2016:NUTS CODE="ES300"/><MAIN_SITE><P>Hospital Universitario Fundación Alcorcón.</P></MAIN_SITE><SHORT_DESCR><P>Suministro de medicamentos exclusivos de Novartis Farmacéutica, S. A., para el Hospital Universitario Fundación Alcorcón.</P></SHORT_DESCR><AC><AC_PRICE/></AC><NO_OPTIONS/><NO_EU_PROGR_RELATED/></OBJECT_DESCR></OBJECT_CONTRACT><PROCEDURE><PT_AWARD_CONTRACT_WITHOUT_CALL><D_ACCORDANCE_ARTICLE><D_MANUF_FOR_RESEARCH CTYPE="SUPPLIES"/><D_TECHNICAL/></D_ACCORDANCE_ARTICLE><D_JUSTIFICATION><P>El expediente objeto de este contrato es de suministros, artículo 16.3.a) de la Ley 9/2017, de 9 de noviembre, de Contratos del Sector Público, y de acuerdo al apartado a) 2.º del artículo 168 de la Ley 9/2017. Por tratarse de medicamentos de distribución exclusiva de una sola empresa en el territorio nacional, se considera aplicable el procedimiento negociado sin publicidad.</P></D_JUSTIFICATION></PT_AWARD_CONTRACT_WITHOUT_CALL><NO_CONTRACT_COVERED_GPA/></PROCEDURE><AWARD_CONTRACT ITEM="1"><CONTRACT_NO>1</CONTRACT_NO><LOT_NO>1</LOT_NO><TITLE><P>Suministro de medicamentos exclusivos de Novartis Farmacéutica, S. A., para el Hospital Universitario Fundación Alcorcón</P></TITLE><AWARDED_CONTRACT><DATE_CONCLUSION_CONTRACT>2020-08-03</DATE_CONCLUSION_CONTRACT><TENDERS><NB_TENDERS_RECEIVED>1</NB_TENDERS_RECEIVED><NB_TENDERS_RECEIVED_EMEANS>1</NB_TENDERS_RECEIVED_EMEANS></TENDERS><CONTRACTORS><NO_AWARDED_TO_GROUP/><CONTRACTOR><ADDRESS_CONTRACTOR><OFFICIALNAME>Novartis Farmacéutica, S. A.</OFFICIALNAME><NATIONALID>A08011074</NATIONALID><TOWN>Barcelona</TOWN><POSTAL_CODE>08013</POSTAL_CODE><COUNTRY VALUE="ES"/><n2016:NUTS CODE="ES511"/></ADDRESS_CONTRACTOR><NO_SME/></CONTRACTOR></CONTRACTORS><VALUES><VAL_ESTIMATED_TOTAL CURRENCY="EUR">2893360.00</VAL_ESTIMATED_TOTAL><VAL_TOTAL CURRENCY="EUR">2724077.68</VAL_TOTAL></VALUES></AWARDED_CONTRACT></AWARD_CONTRACT><COMPLEMENTARY_INFO><ADDRESS_REVIEW_BODY><OFFICIALNAME>Tribunal Administrativo de Contratación Pública de la Comunidad de Madrid</OFFICIALNAME><TOWN>Madrid</TOWN><COUNTRY VALUE="ES"/></ADDRESS_REVIEW_BODY><DATE_DISPATCH_NOTICE>2020-08-03</DATE_DISPATCH_NOTICE></COMPLEMENTARY_INFO></F03_2014></FORM_SECTION></TED_EXPORT>